63. 特発性血小板減少性紫斑病 Idiopathic thrombocytopenic purpura Clinical trials / Disease details

臨床試験数 : 391 / 薬物数 : 235 - (DrugBank : 50) / 標的遺伝子数 : 49 - 標的パスウェイ数 : 139

1 trial found

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT05422365 (ClinicalTrials.gov)	July 26, 2022	14/6/2022	Intravenous Immunoglobulin (IVIG, Bioven) Efficacy and Safety in Chronic Primary Immune Thrombocytop ...	Open, Multicenter, International Study to Evaluate the Efficacy, Safety and Tolerability of Bioven, ...	Primary Immune Thrombocytopenia	Drug: Intravenous immunoglobulin (IVIG), 10% solution for infusion	Biopharma Plasma LLC	NULL	Recruiting	18 Years	65 Years	All	36	Phase 3	Ukraine

First Previous1Next Last